Doris Lanz

908 total citations
26 papers, 510 citations indexed

About

Doris Lanz is a scholar working on Pediatrics, Perinatology and Child Health, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Doris Lanz has authored 26 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pediatrics, Perinatology and Child Health, 6 papers in Obstetrics and Gynecology and 5 papers in Surgery. Recurrent topics in Doris Lanz's work include Maternal and fetal healthcare (6 papers), Colorectal Cancer Treatments and Studies (5 papers) and Cancer Treatment and Pharmacology (4 papers). Doris Lanz is often cited by papers focused on Maternal and fetal healthcare (6 papers), Colorectal Cancer Treatments and Studies (5 papers) and Cancer Treatment and Pharmacology (4 papers). Doris Lanz collaborates with scholars based in United Kingdom, Switzerland and Spain. Doris Lanz's co-authors include Daniel Rauch, Markus Borner, A. Roth, Piercarlo Saletti, Dieter Koeberle, Khalid S. Khan, Damien Dietrich, Roger von Moos, Walter Mingrone and Jahnavi Daru and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and American Journal of Obstetrics and Gynecology.

In The Last Decade

Doris Lanz

24 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Doris Lanz United Kingdom	11	223	111	95	68	67	26	510
Kim Jordan United States	11	146 0.7×	104 0.9×	50 0.5×	33 0.5×	9 0.1×	37	590
Charlotte Burmeister United States	14	86 0.4×	69 0.6×	35 0.4×	31 0.5×	23 0.3×	46	456
Kirstin Wilkinson United Kingdom	6	240 1.1×	58 0.5×	86 0.9×	8 0.1×	45 0.7×	11	481
Donal J. Sexton Ireland	15	63 0.3×	75 0.7×	103 1.1×	18 0.3×	10 0.1×	68	671
Alem Mehari United States	14	26 0.1×	210 1.9×	30 0.3×	21 0.3×	13 0.2×	48	658
Yasuhiro Hagiwara Japan	12	182 0.8×	123 1.1×	13 0.1×	42 0.6×	14 0.2×	51	455
Amy Brenner United Kingdom	11	175 0.8×	148 1.3×	81 0.9×	2 0.0×	48 0.7×	16	397
Ambica Parmar Canada	14	186 0.8×	168 1.5×	33 0.3×	38 0.6×	18 0.3×	42	638
Ramy Sedhom United States	14	289 1.3×	148 1.3×	146 1.5×	7 0.1×	10 0.1×	82	696
Cary Jo R. Schlick United States	11	72 0.3×	57 0.5×	14 0.1×	9 0.1×	8 0.1×	40	451

Countries citing papers authored by Doris Lanz

Since Specialization

Citations

This map shows the geographic impact of Doris Lanz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doris Lanz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doris Lanz more than expected).

Fields of papers citing papers by Doris Lanz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doris Lanz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doris Lanz. The network helps show where Doris Lanz may publish in the future.

Co-authorship network of co-authors of Doris Lanz

This figure shows the co-authorship network connecting the top 25 collaborators of Doris Lanz. A scholar is included among the top collaborators of Doris Lanz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doris Lanz. Doris Lanz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Drymoussi, Zoe, Doris Lanz, María del Carmen Pardo, et al.. (2023). Metformin in the prevention of type 2 diabetes after gestational diabetes in postnatal women (OMAhA): a UK multicentre randomised, placebo-controlled, double-blind feasibility trial with nested qualitative study. BMJ Open. 13(11). e073813–e073813. 3 indexed citations

Dibley, Lesley, Ailsa Hart, Charles H. Knowles, et al.. (2023). Supported Intervention Versus Intervention Alone for Management of Fecal Incontinence in Patients With Inflammatory Bowel Disease. Journal of Wound Ostomy and Continence Nursing. 50(3). 235–244. 1 indexed citations

Lanz, Doris, et al.. (2022). Deferred consent in emergency obstetric research: findings from qualitative interviews with women and recruiters in the ACROBAT pilot trial for severe postpartum haemorrhage. BMJ Open. 12(5). e054787–e054787. 7 indexed citations

Lanz, Doris, Zoe Drymoussi, Julie Dodds, et al.. (2021). Acceptability and adherence to a Mediterranean diet in the postnatal period to prevent type 2 diabetes in women with gestational diabetes in the UK: a protocol for a single-arm feasibility study (MERIT). BMJ Open. 11(12). e050099–e050099. 3 indexed citations

Dibley, Lesley, Ailsa Hart, Julie Duncan, et al.. (2020). Clinician Administered and Self-Report Survey Both Effective for Identifying Fecal Incontinence in Patients with Inflammatory Bowel Disease. Digestive Diseases and Sciences. 66(6). 2024–2031. 7 indexed citations

Green, Laura, Jahnavi Daru, Julie Dodds, et al.. (2020). Effect of early cryoprecipitate transfusion versus standard care in women who develop severe postpartum haemorrhage (ACROBAT) in the UK: a protocol for a pilot cluster randomised trial. BMJ Open. 10(6). e036416–e036416. 8 indexed citations

Crowley, Evelyn M., Shaun Treweek, Katie Banister, et al.. (2020). Using systematic data categorisation to quantify the types of data collected in clinical trials: the DataCat project. Trials. 21(1). 535–535. 10 indexed citations

Bhide, Priya, Doris Lanz, Julie Dodds, et al.. (2020). TILT: Time-Lapse Imaging Trial—a pragmatic, multi-centre, three-arm randomised controlled trial to assess the clinical effectiveness and safety of time-lapse imaging in in vitro fertilisation treatment. Trials. 21(1). 600–600. 12 indexed citations

Roberts, Tracy, Louise Jackson, Philip Moore, et al.. (2019). Cost-effectiveness of cell salvage and donor blood transfusion during caesarean section: results from a randomised controlled trial. BMJ Open. 9(2). e022352–e022352. 9 indexed citations

10.

Khan, Khalid S., Philip Moore, Matthew Wilson, et al.. (2018). A randomised controlled trial and economic evaluation of intraoperative cell salvage during caesarean section in women at risk of haemorrhage: the SALVO (cell SALVage in Obstetrics) trial. Health Technology Assessment. 22(2). 1–88. 46 indexed citations

11.

Norton, Christine, Lesley Dibley, Ailsa Hart, et al.. (2018). PTU-004 Asking about bowel control problems in IBD: results of face-to-face screening versus self-reporting. Queen Mary Research Online (Queen Mary University of London). A64.1–A64.

12.

Khan, Khalid S., Philip Moore, Matthew Wilson, et al.. (2017). Cell salvage and donor blood transfusion during cesarean section: A pragmatic, multicentre randomised controlled trial (SALVO). PLoS Medicine. 14(12). e1002471–e1002471. 40 indexed citations

13.

Moss, Ngawai, Jahnavi Daru, Doris Lanz, Shakila Thangaratinam, & Khalid S. Khan. (2016). Involving pregnant women, mothers and members of the public to improve the quality of women's health research. BJOG An International Journal of Obstetrics & Gynaecology. 124(3). 362–365. 27 indexed citations

14.

Stansfeld, Stephen, Sally Kerry, Tarani Chandola, et al.. (2015). Pilot study of a cluster randomised trial of a guided e-learning health promotion intervention for managers based on management standards for the improvement of employee well-being and reduction of sickness absence: GEM Study. BMJ Open. 5(10). e007981–e007981. 34 indexed citations

15.

Moos, Roger von, Arnaud Roth, Thomas Ruhstaller, et al.. (2010). Oxaliplatin, Irinotecan and Capecitabine (OCX) for First-Line Treatment of Advanced/Metastatic Colorectal Cancer: A Phase I Trial (SAKK 41/03). Onkologie. 33(6). 295–299. 3 indexed citations

16.

Schuller, Jan C., Michael Mayer, Doris Lanz, et al.. (2009). A novel diagram and complement to the CONSORT chart for presenting multimodal clinical trials. Contemporary Clinical Trials. 30(3). 201–204. 2 indexed citations

17.

Lanz, Doris, et al.. (2008). Sándor Veress : Komponist -- Lehrer -- Forscher. Bärenreiter eBooks.

18.

Borner, Markus, Dieter Koeberle, Roger von Moos, et al.. (2008). Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK. Annals of Oncology. 19(7). 1288–1292. 108 indexed citations

19.

Rochlitz, Christoph, Walter Mingrone, Bernhard C. Pestalozzi, et al.. (2006). Efficacy and Tolerability of Capecitabine with Weekly Paclitaxel for Patients with Metastatic Breast Cancer: A Phase II Report of the SAKK. Oncology. 71(1-2). 54–60. 8 indexed citations

20.

Borner, Markus, J. Bernhard, Damien Dietrich, et al.. (2005). A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity. Annals of Oncology. 16(2). 282–288. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact